SFX by Ex Libris Inc.

Title:	Prevention of graft versus host disease by inactivation of host antigen-presenting cells
Source:	Science [0036-8075] Shlomchik, W D yr:1999

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Efron, B. "Bootstrap Methods: Another Look at the Jackknife." The annals of statistics 7.1 (1979): 1-26.
description	2.	Sullivan, K M M. "Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppression." Blood 57.2 (1981): 267-76.
description	3.	Liu, J. "Selective T-cell subset ablation demonstrates a role for T1 and T2 cells in ongoing acute graft-versus-host disease: a model system for the reversal of disease." Blood 98.12 (2001): 3367-3375.
description	4.	Kaplan, Daniel H H. "Target antigens determine graft-versus-host disease phenotype." The journal of immunology 173.9 (1950): 5467-75.
description	5.	Choksi, S. "A CD8 DE loop peptide analog prevents graft-versus-host disease in a multiple minor histocompatibility antigen-mismatched bone marrow transplantation model." Biology of blood and marrow transplantation 10.10 (2004): 669-680.
description	6.	Efron, B. "A Leisurely Look at the Bootstrap, the Jackknife, and Cross-Validation." American Statistician, The 37.1 (1983): 36-48.
description	7.	Efron, B. "Bootstrap Methods for Standard Errors, Confidence Intervals, and Other Measures of Statistical Accuracy." Statistical science 1.1 (1986): 54-77.
description	8.	Efron, B. "Improvements on Cross-Validation: The. 632+ Bootstrap Method." Journal of the American Statistical Association 92.438 (1997): 548-560.
description	9.	MILLER, Rupert G. "The jackknife-a review." Biometrika 61.1 (1974): 1-15.
description	10.	Felsenstein, J. "Confidence Limits on Phylogenies: An Approach Using the Bootstrap." Evolution 39.4 (1985): 783-791.
description	11.	Abraham, David J J. "Scleroderma: from cell and molecular mechanisms to disease models." Trends in immunology 26.11: 587-595.
description	12.	Michael, M. "Recent compounds for immunosuppression and experimental therapies for acute graft-versus-host disease." The Israel Medical Association journal 15.1 (2013): 44-50.
description	13.	Emerson, Stephen G G. "Tanning before transplant: lancing the Langerhans cell." Nature medicine 10.5 (2004): 451-2.
description	14.	Matte, Jennifer C. "Donor APCs are required for maximal GVHD but not for GVL." Nature medicine 10.9 (2004): 987-92.
description	15.	Hunig, N. "Protection from graft-versus-host disease with a novel B7 binding site-specific mouse anti-mouse CD28 monoclonal antibody." Blood 112.10 (2008): 4328-36.
description	16.	Anderson, Britt E E. "Memory CD4+ T cells do not induce graft-versus-host disease." The journal of clinical investigation 112.1 (2003): 101-8.
description	17.	Anderson, Britt E E. "Distinct roles for donor- and host-derived antigen-presenting cells and costimulatory molecules in murine chronic graft-versus-host disease: requirements depend on target organ." Blood 105.5 (2005): 2227-34.
description	18.	Hubbard, Vanessa M M. "Absence of inducible costimulator on alloreactive T cells reduces graft versus host disease and induces Th2 deviation." Blood 106.9 (2005): 3285-92.
description	19.	Efron, B. "Estimating the error rate of a prediction rule: improvement on cross-validation." Journal of the American Statistical Association 78.382 (1983): 316-331.
description	20.	Gong, G. "Cross-validation, the jackknife, and the bootstrap: Excess error estimation in forward logistic regression." Journal of the American Statistical Association 81.393 (1986): 108-113.